期刊文献+

高通量血液透析对终末期糖尿病肾病患者毒素清除效果及氧化应激的影响 被引量:6

Effects of High-flux Hemodialysis on Toxin Clearance and Oxidative Stress in Patients with End-stage Diabetic Nephropathy
下载PDF
导出
摘要 目的探讨高通量血液透析(HFHD)对终末期糖尿病肾病(ESDN)患者毒素清除效果及氧化应激的影响。方法收集2018年10月-2019年10月我院收治的200例ESDN患者临床资料,将采用普通血液透析(HD)治疗的98例患者研究资料纳入对照组,将采用HFHD治疗的102例患者研究资料纳入观察组,治疗6个月后,比较两组毒素清除效果〔视黄醇结合蛋白(RBP)、甲状旁腺素(PTH)、血肌酐(SCr)、氧化应激水平〔谷胱甘肽过氧化物酶(GSH-Px)、超氧化物歧化酶(SOD)、丙二醛(MDA)〕。结果治疗后,两组RBP、PTH及SCr水平均较治疗前降低,且观察组低于对照组,差异有统计学意义(P<0.05);治疗后,较治疗前相比,观察组GSH-Px、SOD水平升高,且高于对照组,MDA水平降低,且低于对照组,差异有统计学意义(P<0.05)。结论ESDN患者应用HFHD治疗,能够有效清除其血液中毒素,改善氧化应激水平。 Objective This paper aims to investigate the effect of high-flux hemodialysis(HFHD)on toxin clearance and oxidative stress in patients with end-stage diabetic nephropathy(ESDN).Methods The clinical data of 200 ESDN patients admitted to our hospital from October 2018 to October 2019 were collected.The study data of 98 patients treated with general hemodialysis(HD)were included in the control group,and 102 patients treated with HFHD were included The study data were included in the observation group.After 6 months of treatment,the toxin clearance effects〔retinol binding protein(RBP),parathyroid hormone(PTH),blood creatinine(SCr)〕and the level of oxidative stress were compared.Glutathione peroxidase(GSH-Px),superoxide dismutase(SOD),malondialdehyde(MDA)〕.Results After treatment,the RBP,PTH and SCr levels of the two groups were lower than before treatment,and the observation group was lower than the control group,the difference was statistically significant(P<0.05);after treatment,compared with before treatment,the observation group GSH-Px and SOD levels increased and were higher than the control group,MDA levels decreased and lower than the control group,the difference was statistically significant(P<0.05).Conclusion ESDN patients treated with HFHD can effectively remove toxins from their blood and improve the level of oxidative stress.
作者 芮秀颖 RUI Xiu-ying(Department of General Medicine,Baodi District People's Hospital,Tianjin 301800,China)
出处 《透析与人工器官》 2020年第3期40-41,47,共3页 Chinese Journal of Dialysis and Artificial Organs
关键词 糖尿病肾病 高通量血液透析 毒素清除效果 氧化应激 diabetic nephropathy high-flux hemodialysis toxin removal effect oxidative stress
  • 相关文献

参考文献10

二级参考文献83

  • 1Montserrat B Duran-Salgado,Alberto F Rubio-Guerra.Diabetic nephropathy and inflammation[J].World Journal of Diabetes,2014,5(3):393-398. 被引量:169
  • 2王质刚.终末期糖尿病肾病血液透析并发症的防治[J].中国实用内科杂志,2007,27(22):1742-1744. 被引量:17
  • 3Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012,379(9818):815-822.
  • 4Parving HH, Lewis JB, Ravid M, et al. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective[J]. Kidney Int, 2006,69(11):2057-2063.
  • 5Liu ZH. Nephrology in China[J]. Nat Rev Nephrol, 2013,9(9):523-528.
  • 6Woodward M, Patel A, Zoungas S, et al. Does glycemic control offer similar benefits among patients with diabetes in different regions of the world? Results from the ADVANCE trial[J]. Diabetes Care, 2011,34(12):2491-2495.
  • 7Zhuo L, Zou G, Li W, et al. Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus[J]. Eur J Med Res, 2013,18:4.
  • 8KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease[J]. Am J Kidney Dis, 2007,49(2 Suppl 2):S12-S154.
  • 9American Diabetes Association. Standards of medical care in diabetes--2014[J]. Diabetes Care, 2014,37(Suppl 1):S14-S80.
  • 10KDOQI. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease[J]. Kidney Int Suppl, 2013,3(1):1-150.

共引文献514

同被引文献76

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部